Condition: Inflammatory Myositis · Idiopathic Inflammatory Myositis · Drug-induced Inflammatory Myositis · Sponsor: Assistance Publique - Hôpitaux de Paris
Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities
This description comes directly from the study's public registry record.
Joe-Elie SALEM, MD PhD · 142178531 · joe-elie.salem@aphp.fr
Olivier Benveniste, PU PH · olivier.benveniste@aphp.fr
Always discuss trial participation with your own doctor first.
| Département de médecine interne et immunolgie clinique, Hôpital Pitié Salpêtrière | Paris, France | Recruiting |
| Département de pharmacologie clinique, Hôpital Pitié Salpêtrière | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05454527